Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker KRSA
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | JPMorgan Chase & Co. | 2.69M | 5.9% | SCHEDULE 13G ↗ |
| Oct 15, 2026 | SCHEDULE 13G/A (amended) | KRSA Korsana Biosciences, Inc. | Jason Wood | 25,974 | 0.1% | SCHEDULE 13G/A ↗ |
| Oct 15, 2026 | SCHEDULE 13G/A (amended) | KRSA Korsana Biosciences, Inc. | J. Wood Capital Advisors LLC | 25,974 | 0.1% | SCHEDULE 13G/A ↗ |
| Oct 7, 2026 | SCHEDULE 13G/A (amended) | KRSA Korsana Biosciences, Inc. | Abigail P. Johnson | 3.14M | 6.9% | SCHEDULE 13G/A ↗ |
| Oct 7, 2026 | SCHEDULE 13G/A (amended) | KRSA Korsana Biosciences, Inc. | FMR LLC | 3.14M | 6.9% | SCHEDULE 13G/A ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic Partners (Lux) SCSp | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic GenPar (Lux) SCSp | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic (Lux) S.a r.l. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | GAP (Bermuda) L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic (KB), L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic GenPar, L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic GenPar (Bermuda), L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic (SPV) GP, LLC | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | GAP Holdings GP, LLC | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | GAP Coinvestments PE Holdco GP, L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | GAP Coinvestments PE Holdco, L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | GAP Coinvestments CDA, L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | GAP Coinvestments V, LLC | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | GAP Coinvestments IV, LLC | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | GAP Coinvestments III, LLC | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic Partners 100, L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 18, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | General Atlantic, L.P. | 3.20M | 6.8% | SCHEDULE 13G ↗ |
| Sep 16, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 2.78M | 6.1% | SCHEDULE 13G ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Nimish Shah | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Bong Y. Koh | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | VHCP Management XP, LLC | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | VHCP Management EG, LLC | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | VHCP Management III, LLC | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Venrock Healthcare Capital Partners XP, L.P. | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Venrock Healthcare Capital Partners EG, L.P. | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | VHCP Co-Investment Holdings III, LLC | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 15, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Venrock Healthcare Capital Partners III, L.P. | 4.55M | 9.9% | SCHEDULE 13D ↗ |
| Sep 11, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Tomas Kiselak | 9.11M | 20.0% | SCHEDULE 13D ↗ |
| Sep 11, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Peter Evan Harwin | 9.10M | 20.0% | SCHEDULE 13D ↗ |
| Sep 11, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Fairmount Healthcare Co-Invest VI L.P. | 2.19M | 4.8% | SCHEDULE 13D ↗ |
| Sep 11, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Fairmount Healthcare Fund II L.P. | 6.91M | 15.2% | SCHEDULE 13D ↗ |
| Sep 11, 2026 | SCHEDULE 13D | KRSA Korsana Biosciences, Inc. | Fairmount Funds Management LLC | 9.10M | 20.0% | SCHEDULE 13D ↗ |
| Aug 14, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Dmitry Balyasny | 317,511 | 7.3% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Dames GP LLC | 317,511 | 7.3% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Balyasny Asset Management Holdings LP | 317,511 | 7.3% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Bam GP LLC | 317,511 | 7.3% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Balyasny Asset Management L.P. | 317,511 | 7.3% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Daniel Schneeberger | 298,757 | 7.0% | SCHEDULE 13G ↗ |
| Aug 14, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | ADAR1 Capital Management, LLC | 298,757 | 7.0% | SCHEDULE 13G ↗ |
| Jul 20, 2026 | SCHEDULE 13D/A (amended) | KRSA Korsana Biosciences, Inc. | Peter M. Hecht | 910,240 | 19.4% | SCHEDULE 13D/A ↗ |
| May 7, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Abigail P. Johnson | 649,547 | 15.0% | SCHEDULE 13G ↗ |
| May 7, 2026 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | FMR LLC | 649,547 | 15.0% | SCHEDULE 13G ↗ |
| Oct 17, 2025 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | Jason Wood | 181,818 | 5.4% | SCHEDULE 13G ↗ |
| Oct 17, 2025 | SCHEDULE 13G | KRSA Korsana Biosciences, Inc. | J. Wood Capital Advisors LLC | 181,818 | 5.4% | SCHEDULE 13G ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | KRSA Korsana Biosciences, Inc. | Tyndall Capital Partners, L.P. | 155,187 | 4.8% | SCHEDULE 13G/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 11:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances